Related Experiment Video
Updated: Jun 10, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
A First-Passage Model of Intravitreal Drug Delivery and Residence Time-Influence of Ocular Geometry, Individual
Patricia Lamirande1, Eamonn A Gaffney1, Michael Gertz2
1Wolfson Centre for Mathematical Biology, Mathematical Institute, Andrew Wiles Building, University of Oxford, Oxford, United Kingdom.
Mathematical modeling shows ocular drug residence time depends on eye size and injection site. This helps optimize intravitreal injection frequency for retinal disease treatments.
Area of Science:
- Ocular pharmacokinetics and drug delivery research.
- Biomedical engineering and mathematical modeling.
- Ophthalmology and retinal disease therapeutics.
Background:
- Recurrent intravitreal injections are standard for retinal diseases.
- Minimizing injection frequency requires understanding ocular drug residence time.
- Mathematical modeling can identify factors influencing drug disposition in the eye.
Purpose of the Study:
- To model vitreal diffusion of therapeutics in nonclinical species.
- To investigate the impact of ocular anatomy and injection site on drug disposition in human eyes.
- To identify factors influencing ocular drug residence time.
Main Methods:
- Utilized a first-passage time approach to model drug transport and elimination.
- Constructed 3D ocular geometries for multiple species (mouse, rat, rabbit, monkey, human).
- Derived a scaling relationship for comparing experimental ocular half-lives.
Main Results:
- Ocular drug residence time is dependent on eye size and injection location.
- Posterior vitreous delivery increased half-life and retinal permeation.
- Anterior exit was the primary elimination route; posterior pathway contribution varied by species.
Conclusions:
- Experimental variability in ocular half-life is linked to anatomical differences and injection sites.
- Posterior pathway permeability may explain species-specific pharmacokinetic differences.
- Modeling provides insights for optimizing intravitreal drug delivery strategies.
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model
Zero-order absorption maintains a steady rate irrespective of the amount of drug left to be absorbed, making it a constant process. In the...
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...

